tiprankstipranks
Physiomics Reports Record Contracts Amidst Revenue Dip
Company Announcements

Physiomics Reports Record Contracts Amidst Revenue Dip

Physiomics (GB:PYC) has released an update.

Pick the best stocks and maximize your portfolio:

Physiomics PLC, a leader in mathematical modelling for therapeutic development, reported a record £1.1 million in new contracts for the fiscal year ending June 2024, with over £500k in contracted revenue carried into the next year. Despite these contract wins, the company experienced a 6% drop in total income and an increased operating loss of 17%. The company also completed a strategic repositioning that includes a management reshuffle and the introduction of new services in biostatistics and personalized dosing software.

For further insights into GB:PYC stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskPhysiomics Strengthens Collaboration with Numab Therapeutics
TipRanks UK Auto-Generated NewsdeskPhysiomics Lands Major Contract in Cancer Drug Development
TipRanks UK Auto-Generated NewsdeskPhysiomics Gains Strong Shareholder Support at AGM
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App